SUBSCRIBE
SUBSCRIBE
News   Deals

Norwood Immunology Limited To Seek IPO In US

November 15, 2005 | 
1 min read

15/11/2005 13:53:37. Immune therapy developer and Norwood Abbey (ASX:NAL) subsidiary Norwood Immunology (AIM:NIM) has revealed plans to seek an initial public offering (IPO) in the USA, subject to market conditions. More...

IPO Australia
MORE ON THIS TOPIC
Reaching an agreement. Businessmen shake hands and make a deal. vector
GLP-1
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
November 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Biogen's signage at its headquarters in Massachusetts
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
October 30, 2024
 · 
2 min read
 · 
Heather McKenzie
Podcast
Pfizer’s Q3 Earnings Win, Deals Galore, Countdown to Election, More
October 30, 2024
 · 
1 min read
 · 
Heather McKenzie
Human hand showing modern buildings and skyscrapers with a colored background. Collage art
NextGen
10 Years of NextGen Honorees: Where Are They Now?
October 30, 2024
 · 
8 min read
 · 
Annalee Armstrong